Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(12)
DRUG(3)
BIOLOGICAL(3)
PROCEDURE(2)
bevacizumab
2 trials
phase_2
alliance-for-clinical-trials-in-oncology
oncolytic measles virus encoding thyroidal sodium iodide symporter
2 trials
phase_1phase_1_2
mayo-clinic
laboratory biomarker analysis
2 trials
phase_1phase_1_2
mayo-clinic
Computed Tomography
1 trial
phase_1_2
mayo-clinic
pyrazoloacridine
1 trial
phase_2
national-cancer-institute-nci
Chest Radiography
1 trial
phase_1_2
mayo-clinic
Echocardiography
1 trial
phase_1_2
mayo-clinic
Biospecimen Collection
1 trial
phase_1_2
mayo-clinic

+9 more interventions

17 unique interventions4 categories

Analytics

Trial Phases

Phase 12
Phase 24

Trial Status

Completed4
Other1

Role Distribution

Principal Investigator1
Other Roles4
PI Rate20%

Activity Timeline

Clinical Trials (5)

NCT02068794Phase 1/2Active Not Recruiting
MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
PrincipalinvestigatorStart date: 2014-04-25
NCT00892177Phase 2Completed
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Glioblastoma Multiforme
StudychairStart date: 2009-10-01
NCT00621686Phase 2Completed
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Brain and Central Nervous System Tumors
StudychairStart date: 2008-09-01
NCT00408590Phase 1Completed
Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Ovarian CancerPrimary Peritoneal Cavity Cancer
StudychairStart date: 2004-04-19
NCT00005976Phase 2Completed
Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma
Brain and Central Nervous System Tumors
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jeffrey Raizer, MD

Northwestern University

Related
8 trials

Shared therapeutic areas:

Brain and Central Nervous System TumorsGlioblastoma Multiforme

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Paul Sabbatini, MD

Memorial Sloan Kettering Cancer Center

Related
14 trials

Shared therapeutic areas:

Ovary CancerPrimary Peritoneal Cavity Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Carcinoma
Similarity Score3%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Glioblastoma MultiformeOvary Cancer
Similarity Score3%

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Related
16 trials

Shared therapeutic areas:

Ovary CancerBrain and Central Nervous System Tumors

Worked with same sponsors:

Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)
Similarity Score3%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score1%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score1%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score1%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score1%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Ovary Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT02068794Phase 1/2PrincipalInvestigator

MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
Active Not Recruiting
NCT00892177Phase 2StudyChair

Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

Glioblastoma Multiforme
Completed
NCT00621686Phase 2StudyChair

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors
Completed
NCT00408590Phase 1StudyChair

Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Ovarian CancerPrimary Peritoneal Cavity Cancer
Completed
NCT00005976Phase 2StudyChair

Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent Glioma

Brain and Central Nervous System Tumors
Completed

All 5 trials loaded